Clinical Trials

In clinical trials, new diagnostic and therapeutic methods as well as hypotheses about the predictability of therapy effectiveness are tested and validated. Within the scope of these trials, we cooperate with other hospitals, universities, and general practitioners.

Protect AD

It is normal to be afraid of some things. But some people's fears are so intense and severe that their daily lives are hindered - they suffer from an anxiety disorder. It can be quite difficult to find an appropriate and suitable therapy for such a disorder. Patients are often faced with long waiting times and therapies of limited effectiveness.

Our goal is an intense short-term therapy which is not only available for all patients but also has a high long-term effectiveness.

Please find more information

Non-invasive brain stimulation in the psychotherapy of anxiety disorders

Anxiety disorders are among the most common mental illnesses. With the help of cognitive behavioural therapy (CBT) for anxiety disorders, great improvements can already be achieved, but not all patients benefit sufficiently from this. As a newer method for supplementing or optimizing the therapy of anxiety disorders, our study will use the example of fear of heights to test for the first time whether an activation of a specific brain region induced by a type of magnetic field significantly improves subsequent exposure therapy compared to placebo stimulation.

All study participants receive two exposure treatments in virtual reality. The perceived anxiety is recorded by a questionnaire before and after the therapy. In addition, a follow-up examination is carried out after 6 months.

Further information can be found on the page of the corresponding third-party funded project.

Treatment of major depressive disorders with bilateral theta-burst stimulation

Depression is one of the most common and serious psychiatric disorders. In this study, the effectiveness of theta-burst stimulation (a form of magnetic stimulation) as an augmentative treatment for depression will be tested for its clinical efficacy.

A total of 236 patients will be enrolled in this study who will receive active or placebo stimulation. The treatment is carried out as an additional therapy on every working day for 6 weeks. The sustainability will be evaluated by 1 and 3 month follow-ups.

Further information can be found on the page of the corresponding third-party funded project.

Early Diagnosis of Dementia (Vogel-Study)

With increased life expectancy, age-related memory diseases (e.g. Alzheimer's disease) increase occur more and more frequently. However, small alterations to the brain can be detected years before a patient shows the first symptoms, and an early start of treatment should increase its effectiveness. To date, however, Alzheimer's disease can only be diagnosed in later stages.

We are working on a method for early diagnosis of Alzheimer's disease.

Please find more information

Characterization of Frontotemporal Lobar Degeneration (FTLD Consortium)

The main goal of the FTLD consortium is to develop and evaluate parameters for monitoring patients with early stage and later stage frontotemporal lobar degeneration, in order to eventually devise effective and objective variables for therapeutic strategies.

We also aim at establishing facilities and support for patients as well as their carers. Therefore, we developed a concept for a local counseling group for patients and relatives in cooperation with HALMA, the counseling, supporting and networking center for family member carers in Würzburg.

Please find more information

Contact

schließen